Autonomix Medical (NASDAQ:AMIX – Get Free Report) is one of 237 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its competitors? We will compare Autonomix Medical to similar businesses based on the strength of its valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and profitability.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Autonomix Medical and its competitors, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Autonomix Medical | 0 | 0 | 1 | 0 | 3.00 |
Autonomix Medical Competitors | 1904 | 4901 | 9169 | 268 | 2.48 |
Autonomix Medical currently has a consensus price target of $28.00, indicating a potential upside of 109.58%. As a group, “Surgical & medical instruments” companies have a potential upside of 18.49%. Given Autonomix Medical’s stronger consensus rating and higher possible upside, equities analysts clearly believe Autonomix Medical is more favorable than its competitors.
Valuation & Earnings
Gross Revenue | Net Income | Price/Earnings Ratio | |
Autonomix Medical | N/A | -$15.43 million | -0.83 |
Autonomix Medical Competitors | $1.01 billion | $10.43 million | -6.26 |
Autonomix Medical’s competitors have higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Profitability
This table compares Autonomix Medical and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Autonomix Medical | N/A | -542.11% | -236.92% |
Autonomix Medical Competitors | -570.81% | -156.88% | -27.81% |
Insider and Institutional Ownership
10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 47.7% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 32.4% of Autonomix Medical shares are held by company insiders. Comparatively, 15.3% of shares of all “Surgical & medical instruments” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
About Autonomix Medical
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.